OM Share Price | Outset Medical, Inc. Stock Analysis & Recommendation

Q: How big is Outset Medical, Inc.?

Market Cap: As of Jun 18, Outset Medical, Inc. has a market capitalization of 335.66 million, categorized as a Micro Cap.Recent Quarterly Performance: For the latest four quarters, Outset Medical, Inc. reported net sales of 115.28 million and a net profit of -113.81 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 26.82 million and total assets of 275.80 million.

Q: What does Outset Medical, Inc. do?

Overview: Outset Medical, Inc. is a medical technology company that operates in the Pharmaceuticals & Biotechnology industry, offering a dialysis machine called Tablo.Financial Snapshot: Most recent Net Sales: 30 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -26 Million (Quarterly Results - Mar 2025) Market cap: USD 335.66 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.55 Return on Equity: -61.65% Price to Book: 1.98 Contact Details: Address: 3052 Orchard Drive, SAN JOSE CA: 95134 Tel: 1 971 5633083 Fax: 1 302 6555049 Website: https://outsetmedical.com/

Q: Should I buy, sell or hold Outset Medical, Inc.?

Based on the current situation of Outset Medical, Inc., it would be prudent to hold your position in the stock for now. The company has reported its highest operating cash flow and operating profit margins, although they remain negative, indicating ongoing challenges. The negative EBITDA suggests that the company is still in a risky financial position compared to its historical valuations. On a positive note, the stock has seen a 38% increase in profits over the past year, despite generating a 0% return. Additionally, high institutional ownership at 93.99% indicates strong confidence from sophisticated investors, as their stake has increased significantly in the last quarter.Given these factors, holding might be the best course of action until there are clearer signs of improvement in profitability and cash flow.

Q: Is Outset Medical, Inc. technically bullish or bearish?

As of 12 September 2025, the technical trend for Outset Medical, Inc. has changed from mildly bullish to mildly bearish. The weekly MACD is bearish, while the monthly MACD is mildly bullish, indicating mixed signals across time frames. The RSI shows no signal on the weekly chart but is bullish on the monthly chart. Bollinger Bands and KST are both mildly bearish on the weekly and monthly charts. Moving averages indicate a mildly bullish stance on the daily timeframe, while the OBV is mildly bullish weekly but shows no trend monthly. In terms of performance, the stock has returned -14.89% year-to-date compared to the S&P 500's 12.22%, but it has outperformed the S&P 500 with a 45.33% return over the past year versus 17.14%. Overall, the current technical stance is mildly bearish, driven primarily by the bearish weekly MACD and the mixed signals from other indicators.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

222.36 k

Shareholding (Sep 2025)

FII

10.78%

Held by 62 FIIs

DII

48.77%

Held by 42 DIIs

Promoter

0.54%

How big is Outset Medical, Inc.?

22-Jun-2025

As of Jun 18, Outset Medical, Inc. has a market capitalization of 335.66 million and reported net sales of 115.28 million with a net profit of -113.81 million over the latest four quarters.

View full answer

What does Outset Medical, Inc. do?

22-Jun-2025

Outset Medical, Inc. is a medical technology company specializing in dialysis machines, specifically the Tablo. As of March 2025, it reported net sales of $30 million and a net loss of $26 million, with a market cap of $335.66 million.

View full answer

Should I buy, sell or hold Outset Medical, Inc.?

22-Jun-2025

Who are in the management team of Outset Medical, Inc.?

22-Jun-2025

As of March 2022, the management team of Outset Medical, Inc. includes Chairman D. Keith Grossman and Directors Scott Bartos and Karen Drexler.

View full answer

Is Outset Medical, Inc. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, Outset Medical, Inc. shows a mildly bearish technical trend, with mixed signals from indicators like the weekly MACD being bearish and the monthly MACD mildly bullish, while the stock has underperformed year-to-date but outperformed over the past year.

View full answer

Compare Outset Medical, Inc. with Similar Stocks

Mesa Laboratories, Inc.IRadimed Corp.Minerva Surgical, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Positive results in Jun 25

OPERATING CASH FLOW(Y) Highest at USD -67.54 MM
NET PROFIT(HY) Higher at USD -36.65 MM
NET SALES(Q) Highest at USD 31.42 MM

Risky - Negative EBITDA

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 92 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.57

Return on Equity

-55.29%

Price to Book

0.65

Revenue and Profits:

Net Sales:

31 Million

(Quarterly Results - Jun 2025)

Net Profit:

-19 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

801.23%

6 Months

296.12%

1 Year

24.03%

2 Years

-77.69%

3 Years

-75.67%

4 Years

-89.42%

5 Years

0.0%

Outset Medical, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

33.02%

EBIT Growth (5y)

1.09%

EBIT to Interest (avg)

-35.45

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.55

Sales to Capital Employed (avg)

0.47

Tax Ratio

0.39%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.18

EV to EBIT

-3.04

EV to EBITDA

-3.24

EV to Capital Employed

3.62

EV to Sales

2.41

PEG Ratio

Dividend Yield

ROCE (Latest)

-119.04%

ROE (Latest)

-61.65%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 39 Schemes (39.9%)

Foreign Institutions

Held by 62 Foreign Institutions (10.78%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 5.37% vs 1.02% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 28.29% vs -0.78% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "31.40",
          "val2": "29.80",
          "chgp": "5.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-15.70",
          "val2": "-15.10",
          "chgp": "-3.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.50",
          "val2": "3.60",
          "chgp": "-2.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-7.70",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-18.50",
          "val2": "-25.80",
          "chgp": "28.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-536.80%",
          "val2": "-551.50%",
          "chgp": "1.47%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -12.81% vs 13.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 25.93% vs -6.01% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "113.70",
          "val2": "130.40",
          "chgp": "-12.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-102.10",
          "val2": "-164.00",
          "chgp": "37.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "23.90",
          "val2": "12.70",
          "chgp": "88.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-128.00",
          "val2": "-172.80",
          "chgp": "25.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-948.40%",
          "val2": "-1,302.20%",
          "chgp": "35.38%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

31.40

29.80

5.37%

Operating Profit (PBDIT) excl Other Income

-15.70

-15.10

-3.97%

Interest

3.50

3.60

-2.78%

Exceptional Items

0.00

-7.70

100.00%

Consolidate Net Profit

-18.50

-25.80

28.29%

Operating Profit Margin (Excl OI)

-536.80%

-551.50%

1.47%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 5.37% vs 1.02% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 28.29% vs -0.78% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

113.70

130.40

-12.81%

Operating Profit (PBDIT) excl Other Income

-102.10

-164.00

37.74%

Interest

23.90

12.70

88.19%

Exceptional Items

-5.60

0.00

Consolidate Net Profit

-128.00

-172.80

25.93%

Operating Profit Margin (Excl OI)

-948.40%

-1,302.20%

35.38%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -12.81% vs 13.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 25.93% vs -6.01% in Dec 2023

All Annual Results

Company CV

About Outset Medical, Inc.

Outset Medical, Inc.

Pharmaceuticals & Biotechnology

Outset Medical, Inc. is a medical technology company. The Company offers Tablo, a dialysis machine. Tablo offers acute and chronic dialysis. Tablo produces dialysate that’s customized to the patient’s prescription. Its touchscreen guidance and animated instructions enables to train new users. Tablo has integrated water purification and produces dialysis on demand. The other features of Tablo include integrated blood pressure cuff and automated saline bolus and tracking. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels and allows providers to a single platform from the hospital to the home. The three subtypes of hemodialysis that are used in the hospital are Intermittent Hemodialysis (IHD), Slow Low Efficiency Dialysis (SLED) and CRRT. IHD is used at the bedside or an inpatient dialysis unit outside of the ICU, while SLED and CRRT are used in the ICU.

Company Coordinates

Company Details

3052 Orchard Drive , SAN JOSE CA : 95134

Tel: 1 971 5633083

https://outsetmedical.com/

Registrar Details

Outset Medical, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Outset Medical, Inc.?

Watch in Real-Time

What does Outset Medical, Inc. do?

Should I buy, sell or hold Outset Medical, Inc.?

Who are in the management team of Outset Medical, Inc.?

Is Outset Medical, Inc. technically bullish or bearish?

Compare Outset Medical, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Positive results in Jun 25

Risky - Negative EBITDA

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About Outset Medical, Inc.

Company Coordinates